Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Advanced Tumors × Nivolumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 50 Carcinoma, Non-Small-Cell Lung 45 Carcinoma, Renal Cell 32 Neoplasms 24 Neoplasm Metastasis 21 Colorectal Neoplasms 20 Carcinoma, Hepatocellular 19 Squamous Cell Carcinoma of Head and Neck 17 Stomach Neoplasms 15 Triple Negative Breast Neoplasms 14 Ovarian Neoplasms 14 Lung Neoplasms 11 Pancreatic Neoplasms 10 Hodgkin Disease 10 Carcinoma, Transitional Cell 10 Head and Neck Neoplasms 8 Small Cell Lung Carcinoma 7 Sarcoma 7 Recurrence 7 Urinary Bladder Neoplasms 6 Prostatic Neoplasms 6 Lymphoma, Non-Hodgkin 6 Endometrial Neoplasms 6 Carcinoma, Merkel Cell 6 Breast Neoplasms 6 Advanced Cancer 6 Uterine Cervical Neoplasms 5 Glioblastoma 5 Colonic Neoplasms 5 Uveal Melanoma 4

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02419417 2022-06-16

BET

Bristol-Myers Squibb

Phase 1/2 Completed

83 enrolled 47 charts

Advanced Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡